IGF1 and hepatocellular carcinoma: In the HCC mouse model, the pathogenesis of HCC was shown to be accompanied by e.g., a reduction in IGF-1 and reprogrammed metabolic profiles shifted towards increased glycolysis and lipogenesis [94].